EGFR GENE MUTATION
Clinical trials for EGFR GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new EGFR GENE MUTATION trials appear
Sign up with your email to follow new studies for EGFR GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on deadly brain tumors in new trial
Disease control Recruiting nowThis early-stage trial tests a new treatment called E-SYNC CAR T cells for people with a specific form of glioblastoma, an aggressive brain cancer. The therapy involves taking a patient's own immune cells, modifying them in a lab to better recognize and attack the tumor, and infu…
Matched conditions: EGFR GENE MUTATION
Phase: PHASE1 • Sponsor: Hideho Okada, MD, PhD • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Heart drug may help radiation fight brain tumors in lung cancer patients
Disease control Recruiting nowThis study tests whether adding a nitroglycerin patch (a heart medication) to standard radiation therapy can better shrink brain tumors in people with a specific type of lung cancer (EGFR-mutant non-small cell lung cancer) that has spread to the brain. About 74 adults will receiv…
Matched conditions: EGFR GENE MUTATION
Phase: NA • Sponsor: Instituto Nacional de Cancerologia de Mexico • Aim: Disease control
Last updated May 11, 2026 20:47 UTC
-
Promising combo targets tough lung cancer
Disease control Recruiting nowThis study tests a combination of two drugs, sacituzumab tirumotecan and furmonertinib, in 25 adults with advanced non-squamous non-small cell lung cancer that has an EGFR gene mutation and has worsened after standard treatments. The goal is to see if the combo can shrink tumors …
Matched conditions: EGFR GENE MUTATION
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 04, 2026 16:31 UTC
-
Blood test aims to catch lung cancer in underscreened groups
Diagnosis Recruiting nowThis study is testing a new blood test that looks for DNA from lung cancer cells in the blood. It is for healthy Asian and Latinx adults aged 50 to 80 who do not smoke but are at risk for a type of lung cancer linked to the EGFR gene. The goal is to see if the test can find lung …
Matched conditions: EGFR GENE MUTATION
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Diagnosis
Last updated May 17, 2026 02:20 UTC
-
Lung cancer rebiopsy study seeks to outsmart drug resistance
Knowledge-focused Recruiting nowThis study looks at why some lung cancer cells survive targeted treatment. Researchers will take small tissue samples (biopsies) before and two weeks after starting therapy to spot early signs of resistance. The goal is to find ways to block these survival pathways and make treat…
Matched conditions: EGFR GENE MUTATION
Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC